Aquestive Therapeutics, Inc.
Develops oral film drugs for CNS disorders and severe allergies.
AQST | NDAQ
Overview
Corporate Details
- ISIN(s):
- US03843E1047
- LEI:
- Country:
- United States of America
- Address:
- 30 TECHNOLOGY DRIVE, 7059 WARREN
- Website:
- https://aquestive.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Aquestive Therapeutics, Inc. is a pharmaceutical company specializing in the development and commercialization of medicines delivered through its proprietary PharmFilm® technology. The company leverages this oral film platform to provide novel, non-invasive alternatives to inconvenient or invasive standard-of-care therapies. Aquestive's primary focus is on advancing treatments for central nervous system (CNS) conditions and severe allergies. Its key products in development include Anaphylm™ (epinephrine sublingual film) for anaphylaxis and Libervant® (diazepam buccal film) for managing seizure clusters.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Aquestive Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Aquestive Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Aquestive Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
